“No choice at all”: Pharma companies begrudgingly agree to negotiate prices
arstechnica.com
Eliquis is the costliest of the 10 drugs for Medicare Part D. From June 2022 to May 2023, the program's gross coverage costs for Eliquis reached $16.5 billion to supply the drug to 3.7 million enrollees. In 2022, out-of-pocket costs per enrollee averaged $441. Bristol Meyers Squibb and partner Pfize
1 Users
0 Comments
2 Highlights
2 Notes
Top Highlights
- Eliquis is the costliest of the 10 drugs for Medicare Part D. From June 2022 to May 2023, the program's gross coverage costs for Eliquis reached $16.5 billion to supply the drug to 3.7 million enrollees. In 2022, out-of-pocket costs per enrollee averaged $441. Bristol Meyers Squibb and partner Pfizer have ratcheted up the drug's price considerably ...
- Likewise, Januvia saw its list price increase 275 percent since its introduction in 2006, and Jardiance's list price increased 97 percent since its 2014 debut. Farxiga
Domain
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.